These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 35853727

  • 1. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T, Qi H, Shen L, Wu Y, Song Z, Cao F, Liu Y, Xie L, Chen S, Tang T, Li H, Zhang Y, Feng L, Zhang H, Chen J, Fan W.
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [Abstract] [Full Text] [Related]

  • 2. CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study.
    Chen Z, Fu X, Qiu Z, Mu M, Jiang W, Wang G, Zhong Z, Qi H, Gao F.
    Radiol Oncol; 2023 Mar 01; 57(1):127-139. PubMed ID: 36942903
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L, Li HL, Guo CY, Luo SX.
    Korean J Radiol; 2018 Mar 01; 19(2):237-246. PubMed ID: 29520181
    [Abstract] [Full Text] [Related]

  • 4. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S, Shi M, Shen L, Qi H, Wan W, Cao F, Xie L, Wu Y, Chen G, Mo J, Zhu G, Ye D, Zhang Y, Feng Z, Xu L, Fan W.
    Int J Hyperthermia; 2020 Mar 01; 37(1):384-391. PubMed ID: 32323585
    [Abstract] [Full Text] [Related]

  • 5. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W.
    J Cancer Res Ther; 2020 Mar 01; 16(2):250-257. PubMed ID: 32474509
    [Abstract] [Full Text] [Related]

  • 6. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF, Jia ZY, Yang ZQ, Fan WL, Shi HB.
    Cardiovasc Intervent Radiol; 2017 Nov 01; 40(11):1748-1755. PubMed ID: 28681222
    [Abstract] [Full Text] [Related]

  • 7. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y, Yu H, Qi L, Liu C, Feng Y, Qi J, Li J, Zhu Q.
    Int J Hyperthermia; 2022 Nov 01; 39(1):455-465. PubMed ID: 35271786
    [Abstract] [Full Text] [Related]

  • 8. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep 01; 16(5):1027-1037. PubMed ID: 33004744
    [Abstract] [Full Text] [Related]

  • 9. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
    Shi Q, Zhou X, Zhang Z, Zhang W, Ma J, Yang M, Yu J, Luo J, Liu L, Yan Z.
    Front Immunol; 2022 Sep 01; 13():1097625. PubMed ID: 36703965
    [Abstract] [Full Text] [Related]

  • 10. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY, Fang ZT, Sun HL, An C, Huang ZM, Zhang TQ, Jiang XY, Chen YT, Xu LF, Huang JH.
    Eur Radiol; 2020 Apr 01; 30(4):2377-2390. PubMed ID: 31900694
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM, Lai CX, Zuo MX, An C, Wang XC, Huang JH, Ning E.
    J Cancer Res Ther; 2020 Apr 01; 16(7):1603-1610. PubMed ID: 33565506
    [Abstract] [Full Text] [Related]

  • 12. Transarterial Chemoembolization Combined with Lenvatinib Plus Sequential Microwave Ablation for Large Hepatocellular Carcinoma Beyond Up-to-Seven Criteria: A Retrospective Cohort Study.
    Tang L, Hou Y, Huang Z, Huang J.
    Acad Radiol; 2024 Jul 01; 31(7):2795-2806. PubMed ID: 38290885
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma.
    Wang Y, Li W, Man W, Dong X, Luo Y, Zhang Y, Zhang Y, Dong C, Sun W, Yang P.
    Comput Intell Neurosci; 2022 Jul 01; 2022():9783113. PubMed ID: 35795769
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter arterial chemoembolization alone versus combined with microwave ablation for recurrent small hepatocellular carcinoma after resection: a retrospective comparative study.
    Ji J, Yang W, Shi HB, Liu S, Zhou WZ.
    BMC Gastroenterol; 2022 Jun 29; 22(1):321. PubMed ID: 35768773
    [Abstract] [Full Text] [Related]

  • 15. Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value.
    Liu J, Zhang W, Lu H, Li H, Zhou X, Li J, Han X.
    J Cancer Res Clin Oncol; 2022 Jul 29; 148(7):1781-1788. PubMed ID: 34405295
    [Abstract] [Full Text] [Related]

  • 16. Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis.
    Zhao J, Wu J, He M, Cao M, Lei J, Luo H, Yi F, Ding J, Wei Y, Zhang W.
    Int J Hyperthermia; 2020 Jul 29; 37(1):624-633. PubMed ID: 32525724
    [Abstract] [Full Text] [Related]

  • 17. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT, Laeseke P.
    Abdom Radiol (NY); 2018 Sep 29; 43(9):2497-2504. PubMed ID: 29450606
    [Abstract] [Full Text] [Related]

  • 18. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R, Shen L, Zhao L, Guan Z, Chen Q, Li W.
    Diagn Interv Radiol; 2018 Jul 29; 24(4):219-224. PubMed ID: 29792289
    [Abstract] [Full Text] [Related]

  • 19. Unresectable Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Combined With Microwave Ablation vs. Combined With Cryoablation.
    Wei J, Cui W, Fan W, Wang Y, Li J.
    Front Oncol; 2020 Jul 29; 10():1285. PubMed ID: 32850395
    [Abstract] [Full Text] [Related]

  • 20. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
    Li Z, Jiao D, Han X, Si G, Li Y, Liu J, Xu Y, Zheng B, Zhang X.
    Cancer Imaging; 2020 Jan 30; 20(1):13. PubMed ID: 32000862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.